The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added brain tumor warning to the label.

FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain ...

The FDA has approved a change to the labeling for a Pfizer birth control shot that warns patients of the risk of meningioma, ...

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with the birth control shot.

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

The FDA approved a label update Friday for Pfizer's Depo-Provera birth control shot warning of meningioma—a brain tumor in ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...

Daphne Berryhill is an oncology pharmacist and freelance writer. She loves the collaborative process of creating health content. Her goal as a writer is to offer information that’s meaningful, ...

Provera can affect the results of certain lab tests. Make sure laboratory personnel and all your doctors know you use Provera. Side effects are physical, mental or emotional symptoms which occur in ...